ALB and type 2 diabetes mellitus: As previously described,1 4304 adults with and without type 2 diabetes with baseline eGFR 25 to 75 mL/min per 1.73 m2 and urinary albumin:creatinine ratio of 200 to 5000 mg/g were randomized to either dapagliflozin 10 mg or placebo once daily with a median follow‐up of 2.4 years.